Current anti-obesity pharmacotherapy includes 5 FDA-approved medications: orlistat, phentermine-topiramate, naltrexone-bupropion, liraglutide, and semaglutide (Table 2), as well as phentermine, which is approved only for short term use
Nhiu hng sn xut iu ch glutathione dng vin hoc dng nc ung v nhn c rt nhiu phn hi tt
doi: 10.1016/s0140-6736(78)92823-4
Ocul Surf 10(3):137148 Laurindo LF, Santos ARDOD, Carvalho ACAD, Bechara MD, Guiguer EL, Goulart RDA, Barbalho SM (2023) Phytochemicals and regulation of NF-kB in inflammatory bowel diseases: an overview of in vitro and in vivo effects
The three major risk factors in the development of cataracts are ageing, diabetes and exposure to sunlight [7,8], with ageing considered to be the most prominent [9]